Phase 2 High-Risk Cancer Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations

Prostate CancerBRCA1 MutationBRCA2 Mutation+2 more

Rana McKay, MD32 enrolled6 locationsNCT05498272

Recruiting

Phase 2

SCRT + mFOLFOX6 + PD-1 Antibody + Targeted Therapy for HIgh-Risk pMMR/MSS Rectal Cancer

Rectal AdenocarcinomaHigh-Risk CancerMSS

Sixth Affiliated Hospital, Sun Yat-sen University49 enrolled1 locationNCT06908031